Winslow Evans & Crocker’s BioMarin Pharmaceuticals BMRN Stock Holding History

Winslow Evans & Crocker’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$7K	Hold	77	–	–	﹤0.01%	1014
2020 Q3	$6K	Hold	77	–	–	﹤0.01%	829
2020 Q2	$9K	Sell	77 -1	-1%	-$99	﹤0.01%	752
2020 Q1	$8K	Hold	78	–	–	﹤0.01%	734
2019 Q4	$8K	Hold	78	–	–	﹤0.01%	851
2019 Q3	$6K	Hold	78	–	–	﹤0.01%	899
2019 Q2	$8K	Sell	78 -10	-11%	-$855	﹤0.01%	861
2019 Q1	$10K	Buy	88 +10	+13%	+$927	﹤0.01%	803
2018 Q4	$8K	Hold	78	–	–	﹤0.01%	798
2018 Q3	$8K	Hold	78	–	–	﹤0.01%	817
2018 Q2	$8K	Hold	78	–	–	﹤0.01%	829
2018 Q1	$6.24K	Hold	78	–	–	﹤0.01%	879
2017 Q4	$6.87K	Hold	78	–	–	﹤0.01%	880
2017 Q3	$7.17K	Buy	78 +1	+1%	+$88	﹤0.01%	873
2017 Q2	$6.99K	Sell	77 -1	-1%	-$91	﹤0.01%	990
2017 Q1	$6.76K	Hold	78	–	–	﹤0.01%	976
2016 Q4	$6.38K	Hold	78	–	–	﹤0.01%	989
2016 Q3	$7.13K	Hold	78	–	–	﹤0.01%	984
2016 Q2	$5.99K	Buy	78 +1	+1%	+$85	﹤0.01%	991
2016 Q1	$6.35K	Sell	77 -1	-1%	-$81	﹤0.01%	973
2015 Q4	$8.07K	Hold	78	–	–	﹤0.01%	955
2015 Q3	$8.11K	Hold	78	–	–	﹤0.01%	935
2015 Q2	$10.5K	Hold	78	–	–	﹤0.01%	918
2015 Q1	$9.6K	Hold	78	–	–	﹤0.01%	888
2014 Q4	$6.96K	Hold	78	–	–	﹤0.01%	968
2014 Q3	$5.56K	Sell	78 -50	-39%	-$3.29K	﹤0.01%	1051
2014 Q2	$7.96K	Buy	128 +51	+66%	+$3.08K	﹤0.01%	908
2014 Q1	$5.25K	Sell	77 -75	-49%	-$5.53K	﹤0.01%	1008
2013 Q4	$11K	Buy	+152	New	+$10.3K	﹤0.01%	864

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Winslow Evans & Crocker's BMRN Position: Q4 2020 in Review

Winslow Evans & Crocker held its BioMarin Pharmaceuticals (BMRN) position steady in Q4 2020 at 77 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Winslow Evans & Crocker first reported a position in BMRN in Q4 2013 and has held it in 29 quarters since. The position peaked at $11K in Q4 2013. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2020.

Winslow Evans & Crocker held 77 shares of BioMarin Pharmaceuticals worth $7K as of Q4 2020.
Winslow Evans & Crocker left its BioMarin Pharmaceuticals share count unchanged in Q4 2020.
BioMarin Pharmaceuticals made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1014 holding.
Winslow Evans & Crocker first reported a position in BioMarin Pharmaceuticals in Q4 2013 and has held it in 29 quarters since.
Winslow Evans & Crocker's BioMarin Pharmaceuticals position peaked at $11K in Q4 2013.
539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.